Stay updated on Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.

Latest updates to the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page
- Check3 days agoChange DetectedNew help and navigation sections were added to the study page, and the Intervention/Treatment heading was reformatted; an older revision label was removed in favor of the updated site version.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small internal update to the ClinicalTrials.gov page without altering the study information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the page. This update appears to be a minor metadata change without altering the reported study details or layout.SummaryDifference0.1%

- Check45 days agoChange DetectedThe collaborators list was updated to replace Instituto de Patologia e Imunologia Molecular da Universidade do Porto with Universidade do Porto as a study collaborator.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s revision/version indicator is updated from **v3.5.2** to **v3.5.3**, reflecting a minor release of the ClinicalTrials.gov page template/software without changing the study details.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.